PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung
Clinical trial NCT05553834 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05553834
- Sponsor
- Duke University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2025-09-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.